Literature DB >> 22565848

The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction.

Michal Kovo1, Letizia Schreiber, Avi Ben-Haroush, Eran Gold, Abraham Golan, Jacob Bar.   

Abstract

OBJECTIVE: To identify pathological placental differences between early-onset and late-onset preeclampsia, in relation to fetal growth restriction (FGR).
METHODS: Placentas from patients with preeclampsia were analyzed for lesions of maternal vascular supply consistent with maternal underperfusion and lesions of fetal vascular supply consistent with fetal thrombo-occlusive disease. Findings were compared between patients who gave birth before 34 weeks (early-onset preeclampsia) and after 34 weeks (late-onset preeclampsia).
RESULTS: Compared with the late-onset group (n = 93), the early-onset group (n = 37) had higher rates of FGR (62.2% vs 25.8%, P < 0.001) and lesions of maternal vascular supply (95% vs 60%, P < 0.001). Within the early-onset group, cases with FGR (n = 23) had more lesions of fetal vascular supply (47.8% vs 7%, P = 0.01), with similar high rates of lesions of maternal vascular supply (91% vs 100%) compared with those without FGR. Within the late-onset preeclampsia group, cases with FGR (n = 24) had higher rates of maternal vascular supply lesions (88% vs 51%, P = 0.003) than those without FGR, but similar rates of fetal vascular supply lesions (25% vs 16%, P = 0.32).
CONCLUSION: The placental fetal vascular supply lesions in combination with maternal vascular lesions are more dominant in early-onset preeclampsia with FGR as compared with early-onset preeclampsia without FGR.
© 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22565848     DOI: 10.1002/pd.3872

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  21 in total

1.  Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation.

Authors:  Angela S Martin; Michael Monsour; Jennifer F Kawwass; Sheree L Boulet; Dmitry M Kissin; Denise J Jamieson
Journal:  Matern Child Health J       Date:  2016-10

2.  Stillbirth, hypertensive disorders of pregnancy, and placental pathology.

Authors:  Karen J Gibbins; Robert M Silver; Halit Pinar; Uma M Reddy; Corette B Parker; Vanessa Thorsten; Marian Willinger; Donald J Dudley; Radek Bukowski; George R Saade; Matthew A Koch; Deborah Conway; Carol J Hogue; Barbara J Stoll; Robert L Goldenberg
Journal:  Placenta       Date:  2016-05-07       Impact factor: 3.481

3.  Expression of notch family proteins in placentas from patients with early-onset severe preeclampsia.

Authors:  Wei-Xiu Zhao; Tao-Tao Huang; Meng Jiang; Ran Feng; Jian-Hua Lin
Journal:  Reprod Sci       Date:  2013-12-13       Impact factor: 3.060

4.  Placental lesions associated with acute atherosis.

Authors:  Yeon Mee Kim; Piya Chaemsaithong; Roberto Romero; Majid Shaman; Chong Jai Kim; Jung-Sun Kim; Faisal Qureshi; Suzanne M Jacques; Ahmed I Ahmed; Tinnakorn Chaiworapongsa; Sonia S Hassan; Lami Yeo; Steven J Korzeniewski
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-30

5.  Effects of excess thromboxane A2 on placental development and nutrient transporters in a Mus musculus model of fetal growth restriction.

Authors:  Karen J Gibbins; Katherine N Gibson-Corley; Ashley S Brown; Matthew Wieben; Richard C Law; Camille M Fung
Journal:  Biol Reprod       Date:  2018-05-01       Impact factor: 4.285

Review 6.  The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease.

Authors:  Juan Lu; Danhua Zhu; Xiaoqian Zhang; Jie Wang; Hongcui Cao; Lanjuan Li
Journal:  Clin Transl Oncol       Date:  2022-09-10       Impact factor: 3.340

7.  Placental Histopathology and Pregnancy Outcomes in "Early" vs. "Late" Placental Abruption.

Authors:  Noa Gonen; Michal Levy; Michal Kovo; Letizia Schreiber; Lilach Kornblit Noy; Eldar Volpert; Jacob Bar; Eran Weiner
Journal:  Reprod Sci       Date:  2020-08-18       Impact factor: 3.060

8.  Placental pathology varies in hypertensive conditions of pregnancy.

Authors:  Jerzy Stanek
Journal:  Virchows Arch       Date:  2017-10-02       Impact factor: 4.064

Review 9.  The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

Authors:  Hajrunisa Cubro; Sonu Kashyap; Meryl C Nath; Allan W Ackerman; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2018-04-30       Impact factor: 5.369

Review 10.  Placental structural abnormalities in gestational diabetes and when they develop: A scoping review.

Authors:  Erin Ehlers; Omonseigho O Talton; Danny J Schust; Laura C Schulz
Journal:  Placenta       Date:  2021-04-26       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.